OPT Machine Vision Tech Co. Ltd. A

OPT has released its 2026 interim report, with net profit attributable to the parent company of 170 million yuan, up 16.78% from the same period last year. Total operating revenue was 904 million yuan, up 32.46% year on year, marking a second consecutive year of growth. Net cash flow from operating activities was negative 168 million yuan, down 247.79% from the same period last year. The company's latest asset-liability ratio was 17.20%, gross margin was 58.61%, return on equity was 5.35%, and diluted earnings per share was 1.40 yuan.

OPT has disclosed its semi-annual report for 2026. In the first half, the company achieved operating revenue of 904 million yuan, up 32.46 percent year on year, and net profit attributable to shareholders of the listed company of 170 million yuan, up 16.78 percent year on year. By downstream industry, revenue from 3C electronics was 426 million yuan, accounting for 47.13 percent of the total. Revenue from the lithium battery industry rose 38.04 percent year on year. Semiconductor industry revenue reached 110 million yuan, a sharp increase of 251.32 percent year on year, while automotive industry revenue was 47.01 million yuan, up 243.20 percent year on year. The company's research and development expenses in the first half reached 139 million yuan, up 7.40 percent year on year, accounting for 15.35 percent of operating revenue. The company plans to distribute a cash dividend of 2.00 yuan per 10 shares, tax included, to all shareholders. The proposal still needs to be submitted to the shareholders' meeting for approval.

This evening, more than 20 companies listed on the Shanghai Stock Exchange released a wave of positive signals, covering share buybacks and stake increases, strong operating results, and interim dividend returns. Four companies announced new buyback plans, with a combined proposed buyback cap of 320 million yuan. Three companies announced new stake increase plans, with a combined proposed increase cap of 166 million yuan. Another six companies disclosed progress updates on buybacks. On the operational front, Pingdingshan Tianan Coal Mining reported a 25.58 percent year-on-year rise in commercial coal sales revenue in the first half. Sichuan Biokin Pharmaceutical received clinical trial approval for its injectable drug BL-B01D1 for subcutaneous administration. Farsoon Technologies posted an 87 percent year-on-year increase in net profit attributable to the parent company in the first half. Jiangsu Beiren Robot System projected a net profit attributable to the parent company of 15.8213 million yuan for the first half of 2026, swinging to a profit. Acter Group reported a 205 percent year-on-year jump in net profit for the first half. In terms of shareholder returns, Eastroc Beverage plans to distribute approximately 2.2 billion yuan in cash dividends for the half year. OPT Machine Vision Tech disclosed that its actual controller has proposed an interim dividend arrangement. And the controlling shareholder of Lead Intelligent Equipment voluntarily committed not to reduce its stake in the company within the next 12 months.